| 摘要 |
The present invention relates to a polymorphism biomarker for predicting prognosis of lung cancer patients, and a method for predicting prognosis of lung cancer using the same, and more specifically, to a polymorphism biomarker for predicting prognosis of lung cancer patients using polymorphism of eight polynucleotide (CD3EAP, TNFRSF10B, AKT1, C3, HOMER2, GNB2L1, CD3D, ADAMTSL3), and to method for predicting prognosis of lung cancer using the same. The present invention provides a marker for prognosis of lung cancer which comprehensively makes a prognosis based on the polymorphism of CD3EAP, TNFRSF10B, AKT1, C3, HOMER2, GNB2L1, CD3D, or ADAMTSL3 after lung cancer surgery, thereby being useful as a customized tool suitable for a genetic predisposition of lung cancer patients. |
